FDA Orange Book
Generic for Thalomid
Thalomid contains thalidomide. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
Yes. The generic name for Thalomid is thalidomide. 1 company holds an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB. Generics match 3 of the 4 Thalomid products the Orange Book lists.
Run it in Rivvi
Map Thalomid and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Thalomid products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| capsule, oral | 100MG | Marketed (Rx) | AB | 1 | AB |
| capsule, oral | 150MG | Marketed (Rx) | None | 0 | None |
| capsule, oral | 200MG | Marketed (Rx) | AB | 1 | AB |
| capsule, oral | 50MG | Marketed (Rx) | AB | 1 | AB |
NDA 020785, held by BRISTOL-MYERS SQUIBB CO. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Approved generic thalidomide
| Company | ANDA | TE code | Approved | Strengths |
|---|---|---|---|---|
| NATCO PHARMA LTD | 213267 | AB (A-rated, therapeutically equivalent) | April 24, 2026 | 100MG, 200MG, 50MG |
Thalomid NDC codes
Questions
Is there a generic for Thalomid?
Yes. The generic name for Thalomid is thalidomide. 1 company holds an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB. Generics match 3 of the 4 Thalomid products the Orange Book lists.
What is the generic name for Thalomid?
The active ingredient in Thalomid is thalidomide, per the FDA Orange Book.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.